| Product Code: ETC13378644 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Type 2 Diabetes Drugs and Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Type 2 Diabetes Drugs and Devices Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Type 2 Diabetes Drugs and Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Type 2 Diabetes Drugs and Devices Market - Industry Life Cycle |
3.4 Europe Type 2 Diabetes Drugs and Devices Market - Porter's Five Forces |
3.5 Europe Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Europe Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 Europe Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.9 Europe Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Europe Type 2 Diabetes Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Type 2 Diabetes Drugs and Devices Market Trends |
6 Europe Type 2 Diabetes Drugs and Devices Market, 2021 - 2031 |
6.1 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Oral Drugs, 2021 - 2031 |
6.1.3 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Injectables, 2021 - 2031 |
6.1.4 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Insulin Therapy, 2021 - 2031 |
6.1.5 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Combination Therapy, 2020 - 2028 |
6.2 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Metformin, 2021 - 2031 |
6.2.3 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By SGLT2 Inhibitors, 2021 - 2031 |
6.2.4 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By GLP-1 Agonists, 2021 - 2031 |
6.2.5 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By DPP-4 Inhibitors, 2021 - 2031 |
6.3 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Glucose Monitors, 2021 - 2031 |
6.3.3 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Insulin Pumps, 2021 - 2031 |
6.3.4 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By CGMs, 2021 - 2031 |
6.3.5 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Smart Insulin Pens, 2021 - 2031 |
6.4 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Pharmacies, 2020 - 2028 |
6.4.5 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Home Care, 2020 - 2028 |
7 Europe Type 2 Diabetes Drugs and Devices Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Germany Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 France Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Poland Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Spain Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Rest of Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Europe Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
7.3.1 United Kingdom (UK) Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.2 Germany Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.3 France Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.4 Poland Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.5 Spain Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.6 Rest of Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4.1 United Kingdom (UK) Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4.2 Germany Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4.3 France Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4.4 Poland Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4.5 Spain Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4.6 Rest of Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.5 Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.1 United Kingdom (UK) Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.2 Germany Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.3 France Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.4 Poland Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.5 Spain Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.6 Rest of Europe Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 Europe Type 2 Diabetes Drugs and Devices Market Key Performance Indicators |
9 Europe Type 2 Diabetes Drugs and Devices Market - Export/Import By Countries Assessment |
10 Europe Type 2 Diabetes Drugs and Devices Market - Opportunity Assessment |
10.1 Europe Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Europe Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.4 Europe Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
10.5 Europe Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By End Use, 2021 & 2031F |
11 Europe Type 2 Diabetes Drugs and Devices Market - Competitive Landscape |
11.1 Europe Type 2 Diabetes Drugs and Devices Market Revenue Share, By Companies, 2022 |
11.2 Europe Type 2 Diabetes Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here